News
TELCOR is excited to share industry news and updates with our stakeholders across the country.
CMS Issues Final Rule Closing Medicare Advantage Loopholes
On April 4, the Centers for Medicare and Medicaid Services issued a final rule making policy and technical changes to the Medicare Advantage (MA) program, Medicare Prescription Drug Benefit program, [...]
Federal Court Final Ruling on FDA Regulation of LDTs
Regarding the ongoing lawsuit challenging the U.S. Food and Drug Administration (FDA) regulation of laboratory-developed tests (LDTs) as medical devices, Judge Sean D. Jordan of the United States District Court, [...]
CMS Releases Updates to CPT and HCPCS Codes
On March 13, the Centers for Medicare and Medicaid Services released updates for CPT and Healthcare Common Procedure Coding System (HCPCS) codes. CPT code G0567 was added to the national [...]
Supreme Court to Hear Challenge to ACA Coverage Mandate for Preventive Services
Updated draft recommendations for cervical cancer screening, released in December by the U.S. Preventive Services Task Force (USPSTF), are being challenged in the U.S. Supreme Court. In updated draft recommendations [...]
Trump Administration Reinforces Price Transparency Requirements for Health Care Services
A recent executive order seeks to reinforce price transparency rules for health care services put in place during the first Trump administration through pricing standardization and stricter enforcement policies. President [...]
Legislation Introduced to Reverse FDA Final Rule on LDTs
Legislators and pathologists alike are expressing opposition to the final rule from the U.S. Food and Drug Administration regulating laboratory-developed tests (LDTs) as medical devices. On Feb. 21, U.S. Reps. [...]
Key Market Trends Impacting RCM Laboratories
In a discussion with Dark Daily, Sarah Stewart, Vice President, Revenue Cycle Services, TELCOR, discusses what’s ahead for clinical lab billing. The following is a brief summary. Revenue cycle management (RCM) [...]
Oral Arguments Heard in Lawsuit Challenging FDA Regulation of LDTs
Oral arguments were heard on Feb. 19 in the ongoing lawsuit challenging the U.S. Food and Drug Administration regulation of laboratory-developed tests (LDTs) as medical devices. The plaintiffs in the [...]
Updates Announced for 2025 Specimen Collection Fees and Travel Allowance Payments
The Centers for Medicare & Medicaid Services made updates to specimen collection fees and travel allowance payments for 2025. Effective Jan. 1, the general specimen collection fee increased from $8.83 [...]
Medicare Administrative Contractors Update Genetic Testing Coverage for Oncology
Medicare Administrative Contractors (MACs) Novitas and FCSO released finalized local coverage determinations (LCDs) for genetic tests for oncology: L39365 and L39367, respectively. The change comes after the College of American [...]